No.199, Tunghwa Rd
Taipei
Taiwan
epidermal growth factor receptor; mutated; non-small-cell lung cancer; phase 1 trial; safety
Asthma, Phenotype clustering, bio-monitoring, Environmental risk, Sphingolipid